ArkeaBio develops a safe and cost-effective methane-reducing vaccine designed to lower greenhouse gas emissions from cattle globally. This scalable bioscience solution integrates seamlessly with existing farm practices to deliver significant climate impact. The vaccine offers value across the agricultural supply chain by reducing emissions efficiently without affecting meat or milk safety.
Funding
$38.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BEFounders
Product
Problem
Ruminant livestock, such as cattle, produce significant methane emissions, contributing over 3 billion tonnes of CO2 equivalents annually to greenhouse gas emissions. These emissions, primarily from the methanogens in the rumen, have a disproportionately high global warming potential compared to carbon dioxide. Current strategies to mitigate these emissions are often costly, difficult to scale, or disruptive to existing agricultural practices.
Solution
ArkeaBio is developing a vaccine that reduces methane emissions from ruminant livestock by targeting and neutralizing methane-producing microbes (methanogens) within the rumen. The vaccine stimulates the animal's immune system to produce antibodies that are delivered to the rumen via saliva. These antibodies bind to methanogens, reducing their population and, consequently, the amount of methane produced during digestion. By reducing methane production, the vaccine also allows the animal to retain more energy from its feed, potentially improving feed efficiency. The vaccine is designed to integrate seamlessly into existing livestock management practices, offering a scalable and cost-effective solution for decarbonizing meat and dairy production.
Target Audience
The primary target audience includes farmers, ranchers, and other livestock producers seeking to reduce the environmental impact of their operations, as well as food producers and governments aiming to meet sustainability targets and reduce the carbon footprint of the agricultural sector.
Features
- Vaccine-induced antibody production targeting key methanogens in the rumen
- Reduction of methane production in the rumen, leading to lower greenhouse gas emissions
- Improved feed efficiency as a result of reduced methane-related energy loss
- Compatibility with existing livestock vaccination protocols and administration methods
- Continuous target refinement based on microbiome analysis to maintain efficacy against evolving methanogen populations
- Scalable manufacturing and distribution to reach a global cattle population
- Designed for safety with no impact on meat or milk quality